273 related articles for article (PubMed ID: 30620726)
1. Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer.
Soukup AA; Zheng Y; Mehta C; Wu J; Liu P; Cao M; Hofmann I; Zhou Y; Zhang J; Johnson KD; Choi K; Keles S; Bresnick EH
J Clin Invest; 2019 Mar; 129(3):1180-1192. PubMed ID: 30620726
[TBL] [Abstract][Full Text] [Related]
2. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
[TBL] [Abstract][Full Text] [Related]
3. Integrating Enhancer Mechanisms to Establish a Hierarchical Blood Development Program.
Mehta C; Johnson KD; Gao X; Ong IM; Katsumura KR; McIver SC; Ranheim EA; Bresnick EH
Cell Rep; 2017 Sep; 20(12):2966-2979. PubMed ID: 28930689
[TBL] [Abstract][Full Text] [Related]
4. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
[TBL] [Abstract][Full Text] [Related]
5. Loss of c-Kit and bone marrow failure upon conditional removal of the GATA-2 C-terminal zinc finger domain in adult mice.
Li HS; Jin J; Liang X; Matatall KA; Ma Y; Zhang H; Ullrich SE; King KY; Sun SC; Watowich SS
Eur J Haematol; 2016 Sep; 97(3):261-70. PubMed ID: 26660446
[TBL] [Abstract][Full Text] [Related]
6. GATA2 +9.5 enhancer: from principles of hematopoiesis to genetic diagnosis in precision medicine.
Soukup AA; Bresnick EH
Curr Opin Hematol; 2020 May; 27(3):163-171. PubMed ID: 32205587
[TBL] [Abstract][Full Text] [Related]
7. Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity.
Johnson KD; Hsu AP; Ryu MJ; Wang J; Gao X; Boyer ME; Liu Y; Lee Y; Calvo KR; Keles S; Zhang J; Holland SM; Bresnick EH
J Clin Invest; 2012 Oct; 122(10):3692-704. PubMed ID: 22996659
[TBL] [Abstract][Full Text] [Related]
8. Human GATA2 mutations and hematologic disease: how many paths to pathogenesis?
Bresnick EH; Jung MM; Katsumura KR
Blood Adv; 2020 Sep; 4(18):4584-4592. PubMed ID: 32960960
[TBL] [Abstract][Full Text] [Related]
9. Mechanism governing a stem cell-generating cis-regulatory element.
Sanalkumar R; Johnson KD; Gao X; Boyer ME; Chang YI; Hewitt KJ; Zhang J; Bresnick EH
Proc Natl Acad Sci U S A; 2014 Mar; 111(12):E1091-100. PubMed ID: 24616499
[TBL] [Abstract][Full Text] [Related]
10. A novel GATA2 distal enhancer mutation results in MonoMAC syndrome in 2 second cousins.
West RR; Bauer TR; Tuschong LM; Embree LJ; Calvo KR; Tillo D; Davis J; Holland SM; Hickstein DD
Blood Adv; 2023 Oct; 7(20):6351-6363. PubMed ID: 37595058
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic human variant that dislocates GATA2 zinc fingers disrupts hematopoietic gene expression and signaling networks.
Jung MM; Shen S; Botten GA; Olender T; Katsumura KR; Johnson KD; Soukup AA; Liu P; Zhang Q; Jensvold ZD; Lewis PW; Beagrie RA; Low JK; Yang L; Mackay JP; Godley LA; Brand M; Xu J; Keles S; Bresnick EH
J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36809258
[TBL] [Abstract][Full Text] [Related]
12. Germline GATA2 Mutation and Bone Marrow Failure.
McReynolds LJ; Calvo KR; Holland SM
Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of GATA2-related myeloid neoplasms.
Hirabayashi S; Wlodarski MW; Kozyra E; Niemeyer CM
Int J Hematol; 2017 Aug; 106(2):175-182. PubMed ID: 28643018
[TBL] [Abstract][Full Text] [Related]
14. Gata2, Fli1, and Scl form a recursively wired gene-regulatory circuit during early hematopoietic development.
Pimanda JE; Ottersbach K; Knezevic K; Kinston S; Chan WY; Wilson NK; Landry JR; Wood AD; Kolb-Kokocinski A; Green AR; Tannahill D; Lacaud G; Kouskoff V; Göttgens B
Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17692-7. PubMed ID: 17962413
[TBL] [Abstract][Full Text] [Related]
15. Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning.
Lim KC; Hosoya T; Brandt W; Ku CJ; Hosoya-Ohmura S; Camper SA; Yamamoto M; Engel JD
J Clin Invest; 2012 Oct; 122(10):3705-17. PubMed ID: 22996665
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic GATA2 genetic variants utilize an obligate enhancer mechanism to distort a multilineage differentiation program.
Katsumura KR; Liu P; Kim JA; Mehta C; Bresnick EH
Proc Natl Acad Sci U S A; 2024 Mar; 121(10):e2317147121. PubMed ID: 38422019
[TBL] [Abstract][Full Text] [Related]
17. Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories.
Johnson KD; Conn DJ; Shishkova E; Katsumura KR; Liu P; Shen S; Ranheim EA; Kraus SG; Wang W; Calvo KR; Hsu AP; Holland SM; Coon JJ; Keles S; Bresnick EH
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32736380
[TBL] [Abstract][Full Text] [Related]
18. Blood disease-causing and -suppressing transcriptional enhancers: general principles and
Bresnick EH; Johnson KD
Blood Adv; 2019 Jul; 3(13):2045-2056. PubMed ID: 31289032
[TBL] [Abstract][Full Text] [Related]
19. Somatic genetic alterations predict hematological progression in GATA2 deficiency.
Largeaud L; Collin M; Monselet N; Vergez F; Fregona V; Larcher L; Hirsch P; Duployez N; Bidet A; Luquet I; Bustamante J; Dufrechou S; Prade N; Nolla M; Hamelle C; Tavitian S; Habib C; Meynier M; Bellanne-Chantelot C; Donadieu J; De Fontbrune FS; Fieschi C; Ferster A; Delhommeau F; Delabesse E; Pasquet M
Haematologica; 2023 Jun; 108(6):1515-1529. PubMed ID: 36727400
[TBL] [Abstract][Full Text] [Related]
20. GATA Factor-G-Protein-Coupled Receptor Circuit Suppresses Hematopoiesis.
Gao X; Wu T; Johnson KD; Lahvic JL; Ranheim EA; Zon LI; Bresnick EH
Stem Cell Reports; 2016 Mar; 6(3):368-82. PubMed ID: 26905203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
